Disciplinary Committee
The Disciplinary Committee will meet at the Royal Pharmaceutical Society of Great Britain, 1 Lambeth High Street, London SE1, on Monday 11, Tuesday 12, Wednesday 13, Thursday 14 and Friday 15 February 2008 at 9.30am to hear the following Statutory Committee inquiries:
1. The new inquiry into a complaint by the Council of the Society against
Rashad Arif (registration number 1069237) which alleges that a number
of dispensing and labelling errors may amount to misconduct.
2. The new inquiry into a complaint by the Council of the Society against
Christopher Dotchin (registration number 1051544) which alleges that:
the removal of a Controlled Drugs Register from a pharmacy; entrusting
the Controlled Drugs Register to someone who was not a pharmacist, thereby
failing to respect and protect the confidentiality of those patients
whose details were contained in the Register; the failure to store appropriately
five or six boxes of Ritalin; storing patient-returned Controlled Drugs
in a locker; the removal of an unknown quantity of date-expired and/or
patient-returned Nicorette gum, Nicorette lozenges and vitamin products
for his own use and without authority; enlisting the services of someone
who was not a pharmacist, was not an employee of the pharmacy and did
not have any pharmaceutical training, and instructing him to sort and
then place on the dispensary shelves medicines which had been previously
dispensed to patients, may amount to misconduct.
3. The new inquiry into a complaint by the Council of the Society against
Andrew Negus (registration number 69957) which alleges that: failing
to make an entry in the morphine Controlled Drug Register (the Register)
on receipt, or within 24 hours of receipt, of 13 bottles of 120ml Oramorph;
making an incorrect and/or deliberately false entry on a pharmacy stock
sheet; making an alteration to the Register without dating the alteration;
failing to make an entry in the Register on the date of a supply of 30ml
bottle of Oramorph, or on the day next following that day, recording
the said supply; giving false information to a Controlled Drug inspector;
asking a colleague to give false information; making a deliberately false
entry in the Register; making an alteration to the Register without dating
the alteration; and being convicted on 26 July 2005 at the Teesside Crown
Court of failing to maintain a Register for a quantity of Oramorph, contrary
to Section 18(1) of the Misuse of Drugs Act 1971, for which Mr Negus
was conditionally discharged for two years and ordered to pay £800
towards the prosecution costs, may amount to misconduct.
Statutory Committees Secretariat |
The
Pharmaceutical Journal